VL
BMY icon

Vima LLC’s Bristol-Myers Squibb BMY Stock Holding History

Vima LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Buy
+190
New +$10.9K 0.01% 267
2024
Q2 		– Sell
-190
Closed -$10.3K – 109
2024
Q1 		$10.3K Hold
190
– – 0.01% 229
2023
Q4 		$9.75K Buy
+190
New +$9.97K 0.02% 246

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Vima LLC's BMY Position: Q2 2026 in Review

Vima LLC opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 190 shares worth $10.9K. The stake represents 0.01% of the portfolio and ranks #267 among its holdings. This is a return to the name: Vima LLC previously reported a position in BMY as recently as Q1 2024.

Vima LLC first reported a position in BMY in Q4 2023 and has held it in 3 quarters since. 1,229 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Vima LLC held 190 shares of Bristol-Myers Squibb worth $10.9K as of Q2 2026.
  • Bristol-Myers Squibb was a new Vima LLC position in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Vima LLC's portfolio in Q2 2026, its #267 holding.
  • Vima LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 3 quarters since.
  • 1,229 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vima LLC's 13F filing for Q2 2026, filed 24 Jul 2026.